MASON QUALLS: Open Payments
NPI 1841751351 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,326 in 104 payments from 21 companies in 2025. Trend: 2023 $506 · 2024 $2,672 · 2025 $2,326
Food & beverage: $2,326
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $294 |
| Janssen Pharmaceuticals, Inc | 10 | $214 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $193 |
| Neurocrine BioSciences, Inc. | 10 | $172 |
| Axsome Therapeutics, Inc. | 6 | $143 |
| Noven Therapeutics, LLC | 7 | $137 |
| Alkermes, Inc. | 5 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $124 |
| Vanda Pharmaceuticals Inc. | 3 | $109 |
| ABBVIE INC. | 5 | $109 |
Products named: REXULTI, CAPLYTA, INGREZZA, Auvelity, Xelstrym, SPRAVATO, TRINTELLIX, VRAYLAR.
Industry payments across FL — which companies pay providers there.
